121 related articles for article (PubMed ID: 22588935)
21. [Relationship between islet beta cell dysfunction and gene expression of uncoupling protein-2 and possible mechanism thereof].
Wang B; Li HL; Yang WY; Xiao JZ; Du RQ; Bai XP; Lou DJ; Pan L
Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(9):630-4. PubMed ID: 18646721
[TBL] [Abstract][Full Text] [Related]
22. Resveratrol up-regulates hepatic uncoupling protein 2 and prevents development of nonalcoholic fatty liver disease in rats fed a high-fat diet.
Poulsen MM; Larsen JØ; Hamilton-Dutoit S; Clasen BF; Jessen N; Paulsen SK; Kjær TN; Richelsen B; Pedersen SB
Nutr Res; 2012 Sep; 32(9):701-8. PubMed ID: 23084643
[TBL] [Abstract][Full Text] [Related]
23. Rat liver uncoupling protein 2: changes induced by a fructose-rich diet.
Castro MC; Massa ML; Del Zotto H; Gagliardino JJ; Francini F
Life Sci; 2011 Oct; 89(17-18):609-14. PubMed ID: 21855553
[TBL] [Abstract][Full Text] [Related]
24. [Influence of genipin and vitamin E on UCP2 and other correlation factors in non-alcoholic fatty liver disease].
Lin L; Guan X; Wang L; Tang Y
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Dec; 27(6):1327-31. PubMed ID: 21374988
[TBL] [Abstract][Full Text] [Related]
25. miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease.
Castro RE; Ferreira DM; Afonso MB; Borralho PM; Machado MV; Cortez-Pinto H; Rodrigues CM
J Hepatol; 2013 Jan; 58(1):119-25. PubMed ID: 22902550
[TBL] [Abstract][Full Text] [Related]
26. [Effects of Electroacupunctrue Combined with Dietary Control on Peroxisome Proliferator-activa- ted Receptor-α, and Liver Fatty Acid-binding Protein Levels in Non-alcoholic Fatty Liver Disease Rats].
Zhang Y; Tang CL; Tian Y; Yuan HZ; Yang H; Tang NZ; Gao RQ; Cao J
Zhen Ci Yan Jiu; 2015 Oct; 40(5):345-51. PubMed ID: 26669188
[TBL] [Abstract][Full Text] [Related]
27. The aggravation of mitochondrial dysfunction in nonalcoholic fatty liver disease accompanied with type 2 diabetes mellitus.
Liu X; Zhang J; Ming Y; Chen X; Zeng M; Mao Y
Scand J Gastroenterol; 2015; 50(9):1152-9. PubMed ID: 25877002
[TBL] [Abstract][Full Text] [Related]
28. A Novel Role of SIRT1/ FGF-21 in Taurine Protection Against Cafeteria Diet-Induced Steatohepatitis in Rats.
Abd Elwahab AH; Ramadan BK; Schaalan MF; Tolba AM
Cell Physiol Biochem; 2017; 43(2):644-659. PubMed ID: 28942443
[TBL] [Abstract][Full Text] [Related]
29. [Study on the mechanism of action of total saponins of Panax notoginseng in ameliorating oxidative stress and insulin resistance in rats fed with high fat diet].
Zhang SS; Wu ZY; Chen JM; Guo QK; Li L; Wang ZF; Gao Y; Ma ZC
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Jan; 34(1):56-61. PubMed ID: 24520789
[TBL] [Abstract][Full Text] [Related]
30. [Therapeutic effect of saxagliptin in rat models of nonalcoholic fatty liver and type 2 diabetes].
Liu Y; Zhang Z; Chen R; Sun J; Chen H
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Jun; 34(6):862-8. PubMed ID: 24968846
[TBL] [Abstract][Full Text] [Related]
31. [Influence of electroacupuncture stimulation on serum and hepatic interleukin-18 expression in nonalcoholic fatty liver rats].
Wang L; Gong B; Zhu LL; Zhuo LS; Li XZ; Zhang QS; Wu F
Zhen Ci Yan Jiu; 2013 Jun; 38(3):208-13. PubMed ID: 24006666
[TBL] [Abstract][Full Text] [Related]
32. Role of APN and TNF-α in type 2 diabetes mellitus complicated by nonalcoholic fatty liver disease.
Lin X; Zhang Z; Chen JM; Xu YY; Ye HR; Cui J; Fang Y; Jin Y; Zhu DR; Yuan L
Genet Mol Res; 2015 Apr; 14(2):2940-6. PubMed ID: 25966055
[TBL] [Abstract][Full Text] [Related]
33. Anti-inflammatory effects of total alkaloids from Rubus alceifolius Poir [corrected]. on non-alcoholic fatty liver disease through regulation of the NF-κB pathway.
Zhao J; Zheng H; Liu Y; Lin J; Zhong X; Xu W; Hong Z; Peng J
Int J Mol Med; 2013 Apr; 31(4):931-7. PubMed ID: 23426790
[TBL] [Abstract][Full Text] [Related]
34. SIRT1 mediates the effect of GLP-1 receptor agonist exenatide on ameliorating hepatic steatosis.
Xu F; Li Z; Zheng X; Liu H; Liang H; Xu H; Chen Z; Zeng K; Weng J
Diabetes; 2014 Nov; 63(11):3637-46. PubMed ID: 24947350
[TBL] [Abstract][Full Text] [Related]
35. [Mechanism study of the protective effects of selective cyclooxygenase-2 enzyme inhibitors on the liver of rats with type 2 diabetes mellitus combined with nonalcoholic steatohepatitis via Rho/ROCK pathway].
Yuan L; Tian F
Zhonghua Gan Zang Bing Za Zhi; 2022 Jan; 30(1):74-80. PubMed ID: 35152673
[No Abstract] [Full Text] [Related]
36. [Serum omega-3 polyunsaturated fatty acid and insulin resistance in type 2 diabetes mellitus and non-alcoholic fatty liver disease].
Zhu QQ; Lou DJ; Si XW; Guan LL; You QY; Yu ZM; Zhang AZ; Li D
Zhonghua Nei Ke Za Zhi; 2010 Apr; 49(4):305-8. PubMed ID: 20627036
[TBL] [Abstract][Full Text] [Related]
37. [UCPs and PPARgamma2 mRNA in diet induced obesity resistant rats].
Yang NH; Wang CJ; Xu MJ; Hu XF
Wei Sheng Yan Jiu; 2005 Sep; 34(5):556-8. PubMed ID: 16329595
[TBL] [Abstract][Full Text] [Related]
38. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
39. [Role of JNK signal transduction pathway in nonalcoholic fatty liver disease].
Tan Y; Zhang JN; Chen JH; Wang LJ; Liu HX
Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):821-5. PubMed ID: 19958640
[TBL] [Abstract][Full Text] [Related]
40. MiR-181b regulates steatosis in nonalcoholic fatty liver disease via targeting SIRT1.
Wang Y; Zhu K; Yu W; Wang H; Liu L; Wu Q; Li S; Guo J
Biochem Biophys Res Commun; 2017 Nov; 493(1):227-232. PubMed ID: 28899784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
